Tema Heart & Health ETF (HRTS)
NASDAQ: HRTS · Real-Time Price · USD
34.32
-0.18 (-0.51%)
At close: May 29, 2026, 4:00 PM EDT
34.33
+0.01 (0.02%)
After-hours: May 29, 2026, 4:15 PM EDT
HRTS Holdings Information
HRTS is an equity ETF with a total of 46 individual holdings. The top holdings are Eli Lilly and Company stock at 11.36%, UnitedHealth Group at 5.33%, Novo Nordisk at 5.20%, Roche Holding AG at 4.53%, and Merck & Co. at 4.35%.
Total Holdings
46
Top 10 Percentage
49.11%
Asset Class
Equity
ETF Category
Health
Assets
51.66M
PE Ratio
20.35
Breakdown by Sector
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 11.36% |
| 2 | UNH | UnitedHealth Group Incorporated | 5.33% |
| 3 | CPH: NOVO.B | Novo Nordisk A/S | 5.20% |
| 4 | RHHBY | Roche Holding AG | 4.53% |
| 5 | MRK | Merck & Co., Inc. | 4.35% |
| 6 | LON: AZN | AstraZeneca PLC | 4.08% |
| 7 | JNJ | Johnson & Johnson | 3.71% |
| 8 | TMO | Thermo Fisher Scientific Inc. | 3.70% |
| 9 | GILD | Gilead Sciences, Inc. | 3.44% |
| 10 | SWX: NOVN | Novartis AG | 3.42% |
| 11 | RVMD | Revolution Medicines, Inc. | 3.25% |
| 12 | VRTX | Vertex Pharmaceuticals Incorporated | 2.88% |
| 13 | ABT | Abbott Laboratories | 2.63% |
| 14 | BBIO | BridgeBio Pharma, Inc. | 2.62% |
| 15 | CYTK | Cytokinetics, Incorporated | 2.55% |
| 16 | DHR | Danaher Corporation | 2.54% |
| 17 | ABBV | AbbVie Inc. | 2.39% |
| 18 | BMY | Bristol-Myers Squibb Company | 2.11% |
| 19 | TEVA | Teva Pharmaceutical Industries Limited | 2.03% |
| 20 | MDT | Medtronic plc | 1.94% |
| 21 | AMGN | Amgen Inc. | 1.92% |
| 22 | DXCM | DexCom, Inc. | 1.84% |
| 23 | EW | Edwards Lifesciences Corporation | 1.76% |
| 24 | MCK | McKesson Corporation | 1.75% |
| 25 | REGN | Regeneron Pharmaceuticals, Inc. | 1.71% |
As of May 26, 2026